| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Nutlin-3 | CTRPv2 | pan-cancer | AAC | -0.14 | 6e-05 |
| mRNA | ML239 | CTRPv2 | pan-cancer | AAC | 0.13 | 0.0005 |
| mRNA | LY-2183240 | CTRPv2 | pan-cancer | AAC | 0.11 | 0.0008 |
| mRNA | Obatoclax Mesylate | GDSC1000 | pan-cancer | AAC | 0.11 | 0.001 |
| mRNA | Pyrimethamine | GDSC1000 | pan-cancer | AAC | 0.17 | 0.001 |
| mRNA | neratinib | CTRPv2 | pan-cancer | AAC | -0.11 | 0.002 |
| mRNA | ibrutinib | CTRPv2 | pan-cancer | AAC | -0.13 | 0.003 |
| mRNA | SID 26681509 | CTRPv2 | pan-cancer | AAC | 0.12 | 0.003 |
| mRNA | lovastatin | CTRPv2 | pan-cancer | AAC | 0.11 | 0.003 |
| mRNA | PD 153035 | CTRPv2 | pan-cancer | AAC | -0.12 | 0.004 |